Distinctive Expression Pattern of ErbB Family Receptors Signifies an Aggressive Variant of Bladder Cancer

Journal of Urology

Volumn 179, Issue 1, 2008, Pages 353-358

  Kassouf, Wassim ^a   Black, Peter C ^b   Tuziak, Tomasz ^b   Bondaruk, Jolanta ^b   Lee, Sangkyou ^b   Brown, Gordon A ^b   Adam, Liana ^b   Wei, Caimiao ^b   Baggerly, Keith ^b   Bar Eli, Menashe ^b   McConkey, David ^b   Czerniak, Bogdan ^b   Dinney, Colin P ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

bladder; carcinoma; microarray analysis; protein tyrosine kinases; urothelium

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; PARAFFIN;

ADULT; AGED; ARTICLE; AUTOMATION; BLADDER CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; QUALITY CONTROL; STAGING; TISSUE MICROARRAY; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 36749029619     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.08.087     Document Type: Article

References (20)

1. Rajkumar T., Stamp G.W., Pandha H.S., Waxman J., and Gullick W.J. Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer. J Pathol 179 (1996) 381
2. Mellon K., Wright C., Kelly P., Horne C.H., and Neal D.E. Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 153 (1995) 919
3. Sriplakich S., Jahnson S., and Karlsson M.G. Epidermal growth factor receptor expression: predictive value for the outcome after cystectomy for bladder cancer?. BJU Int 83 (1999) 498
4. Liukkonen T., Rajala P., Raitanen M., Rintala E., Kaasinen E., and Lipponen P. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group. Eur Urol 36 (1999) 393
5. Miyamoto H., Kubota Y., Noguchi S., Takase K., Matsuzaki J., Moriyama M., et al. C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer. Urology 55 (2000) 679
6. Chow N.H., Chan S.H., Tzai T.S., Ho C.L., and Liu H.S. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. Clin Cancer Res 7 (2001) 1957
7. Sato K., Moriyama M., Mori S., Saito M., Watanuki T., Terada K., et al. An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer 70 (1992) 2493
8. Kim J.H., Tuziak T., Hu L., Wang Z., Bondaruk J., Kim M., et al. Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. Lab Invest 85 (2005) 532
9. Mostofi F.K. Histological typing of urinary bladder tumours. In: Mostofi F.K., Davis C.J., and Sesterhenn I.A. (Eds). Histological Typing of Urinary Bladder Tumours (1999), Springer, New York
10. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumors (1997), John Wiley, New York
11. Sen S., Zhou H., Zhang R.D., Yoon D.S., Vakar-Lopez F., Ito S., et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94 (2002) 1320
12. Nguyen P.L., Swanson P.E., Jaszcz W., Aeppli D.M., Zhang G., Singleton T.P., et al. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis. Am J Clin Pathol 101 (1994) 166
13. Bieche I., Onody P., Tozlu S., Driouch K., Vidaud M., and Lidereau R. Prognostic value of ERBB family mRNA expression in breast carcinomas. Int J Cancer 106 (2003) 758
14. Suo Z., Risberg B., Kalsson M.G., Willman K., Tierens A., Skovlund E., et al. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. J Pathol 196 (2002) 17
15. Memon A.A., Sorensen B.S., Meldgaard P., Fokdal L., Thykjaer T., and Nexo E. The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients. Br J Cancer 94 (2006) 1703
16. Amsellem-Ouazana D., Bieche I., Tozlu S., Botto H., Debre B., and Lidereau R. Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder. J Urol 175 (2006) 1127
17. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707
18. Gullick W.J. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer. Int J Cancer, suppl. 5 (1990) 55
19. Witton C.J., Reeves J.R., Going J.J., Cooke T.G., and Bartlett J.M. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer. J Pathol 200 (2003) 290
20. Pawlowski V., Revillion F., Hebbar M., Hornez L., and Peyrat J.P. Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 6 (2000) 4217